Melanie Cree-Green
Concepts (371)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polycystic Ovary Syndrome | 23 | 2022 | 158 | 12.910 |
Why?
| Insulin Resistance | 57 | 2022 | 1192 | 10.580 |
Why?
| Diabetes Mellitus, Type 2 | 30 | 2023 | 2221 | 4.350 |
Why?
| Obesity | 28 | 2022 | 2786 | 3.890 |
Why?
| Blood Glucose | 36 | 2023 | 1957 | 3.540 |
Why?
| Mitochondria, Muscle | 10 | 2021 | 98 | 3.410 |
Why?
| Glucose Intolerance | 11 | 2021 | 140 | 3.160 |
Why?
| Glucose Clamp Technique | 15 | 2021 | 195 | 2.840 |
Why?
| Metformin | 10 | 2021 | 303 | 2.560 |
Why?
| Muscle, Skeletal | 29 | 2021 | 1556 | 2.500 |
Why?
| Pediatric Obesity | 9 | 2022 | 541 | 2.460 |
Why?
| Triglycerides | 9 | 2022 | 527 | 2.130 |
Why?
| Insulin | 24 | 2022 | 2180 | 2.020 |
Why?
| Adolescent | 67 | 2023 | 18948 | 2.010 |
Why?
| Glucose Tolerance Test | 19 | 2023 | 370 | 1.900 |
Why?
| Fatty Acids, Nonesterified | 7 | 2018 | 173 | 1.800 |
Why?
| Liver | 11 | 2021 | 1827 | 1.780 |
Why?
| Testosterone | 6 | 2023 | 353 | 1.760 |
Why?
| Metabolic Syndrome | 3 | 2020 | 395 | 1.660 |
Why?
| Burns | 9 | 2010 | 256 | 1.650 |
Why?
| Diabetes Mellitus, Type 1 | 16 | 2022 | 3388 | 1.600 |
Why?
| Lipid Metabolism | 6 | 2019 | 482 | 1.530 |
Why?
| Lipolysis | 4 | 2019 | 43 | 1.520 |
Why?
| Hyperinsulinism | 4 | 2019 | 109 | 1.460 |
Why?
| Fasting | 6 | 2022 | 266 | 1.400 |
Why?
| Female | 85 | 2022 | 63629 | 1.390 |
Why?
| Adipose Tissue | 6 | 2022 | 616 | 1.330 |
Why?
| Oxidative Phosphorylation | 4 | 2019 | 160 | 1.280 |
Why?
| Hypoglycemic Agents | 9 | 2019 | 1055 | 1.230 |
Why?
| Child | 47 | 2022 | 19561 | 1.230 |
Why?
| Young Adult | 32 | 2021 | 11094 | 1.220 |
Why?
| Fatty Liver | 3 | 2021 | 254 | 1.220 |
Why?
| Hyperandrogenism | 2 | 2019 | 14 | 1.200 |
Why?
| Cross-Sectional Studies | 21 | 2021 | 4734 | 1.150 |
Why?
| Humans | 106 | 2023 | 122796 | 1.090 |
Why?
| Glucose | 9 | 2023 | 968 | 1.080 |
Why?
| Insulin-Secreting Cells | 6 | 2020 | 333 | 1.070 |
Why?
| Glycerol | 5 | 2019 | 90 | 1.040 |
Why?
| Exercise | 11 | 2022 | 1743 | 1.010 |
Why?
| Cardiovascular Diseases | 6 | 2019 | 1859 | 0.970 |
Why?
| Body Mass Index | 10 | 2021 | 2144 | 0.950 |
Why?
| Magnetic Resonance Spectroscopy | 7 | 2021 | 513 | 0.940 |
Why?
| Gastrointestinal Microbiome | 2 | 2021 | 561 | 0.930 |
Why?
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 141 | 0.930 |
Why?
| Androgens | 2 | 2022 | 169 | 0.930 |
Why?
| Prediabetic State | 4 | 2021 | 236 | 0.910 |
Why?
| Case-Control Studies | 14 | 2021 | 3296 | 0.900 |
Why?
| Circadian Rhythm | 4 | 2019 | 414 | 0.880 |
Why?
| Hyperglycemia | 4 | 2021 | 326 | 0.860 |
Why?
| Non-alcoholic Fatty Liver Disease | 3 | 2021 | 284 | 0.820 |
Why?
| Adult | 40 | 2023 | 32385 | 0.780 |
Why?
| Male | 63 | 2022 | 59639 | 0.780 |
Why?
| Desogestrel | 1 | 2020 | 42 | 0.750 |
Why?
| Adolescent Medicine | 1 | 2020 | 35 | 0.740 |
Why?
| Lipogenesis | 2 | 2019 | 66 | 0.730 |
Why?
| Isotopes | 1 | 2019 | 26 | 0.720 |
Why?
| Endocrinology | 1 | 2020 | 69 | 0.710 |
Why?
| Inservice Training | 1 | 2020 | 105 | 0.700 |
Why?
| Gluconeogenesis | 1 | 2019 | 66 | 0.680 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 46 | 0.680 |
Why?
| Obesity, Abdominal | 1 | 2018 | 39 | 0.670 |
Why?
| Mentors | 1 | 2020 | 170 | 0.660 |
Why?
| Mentoring | 1 | 2020 | 103 | 0.650 |
Why?
| Adenosine Diphosphate | 2 | 2021 | 89 | 0.650 |
Why?
| Interprofessional Relations | 1 | 2020 | 271 | 0.630 |
Why?
| Gynecology | 1 | 2020 | 190 | 0.610 |
Why?
| Adiposity | 4 | 2018 | 523 | 0.610 |
Why?
| Fatty Acids | 2 | 2019 | 410 | 0.610 |
Why?
| Fenofibrate | 2 | 2007 | 24 | 0.600 |
Why?
| Lipoproteins, HDL | 1 | 2017 | 82 | 0.590 |
Why?
| Depressive Disorder | 1 | 2020 | 347 | 0.590 |
Why?
| Amino Acids | 3 | 2019 | 463 | 0.590 |
Why?
| C-Peptide | 5 | 2019 | 137 | 0.590 |
Why?
| Hypolipidemic Agents | 2 | 2007 | 88 | 0.580 |
Why?
| Overweight | 5 | 2021 | 516 | 0.570 |
Why?
| Parenting | 1 | 2020 | 267 | 0.570 |
Why?
| Biodiversity | 1 | 2020 | 386 | 0.570 |
Why?
| Oxygen Consumption | 8 | 2021 | 613 | 0.530 |
Why?
| Muscle Proteins | 7 | 2017 | 218 | 0.510 |
Why?
| Prognosis | 5 | 2020 | 3563 | 0.500 |
Why?
| Lipoproteins | 1 | 2015 | 164 | 0.500 |
Why?
| Aging | 3 | 2019 | 1694 | 0.490 |
Why?
| Bacteria | 1 | 2020 | 772 | 0.470 |
Why?
| Decision Making | 1 | 2020 | 840 | 0.460 |
Why?
| PPAR alpha | 3 | 2007 | 56 | 0.460 |
Why?
| B-Lymphocytes | 1 | 2019 | 936 | 0.460 |
Why?
| Oxygen | 1 | 2018 | 887 | 0.460 |
Why?
| Severity of Illness Index | 3 | 2020 | 2784 | 0.460 |
Why?
| Absorptiometry, Photon | 5 | 2020 | 230 | 0.450 |
Why?
| Sleep | 3 | 2019 | 722 | 0.450 |
Why?
| Bed Rest | 2 | 2009 | 16 | 0.440 |
Why?
| Follow-Up Studies | 6 | 2020 | 4768 | 0.440 |
Why?
| Risk Factors | 11 | 2021 | 9381 | 0.420 |
Why?
| Insulin Glargine | 3 | 2019 | 70 | 0.410 |
Why?
| Mitochondria | 4 | 2021 | 809 | 0.380 |
Why?
| Hirsutism | 2 | 2021 | 10 | 0.370 |
Why?
| Cushing Syndrome | 1 | 2009 | 10 | 0.370 |
Why?
| Gastroplasty | 2 | 2021 | 26 | 0.370 |
Why?
| Internship and Residency | 1 | 2020 | 1065 | 0.360 |
Why?
| Prospective Studies | 7 | 2020 | 6704 | 0.350 |
Why?
| Estradiol | 3 | 2022 | 477 | 0.350 |
Why?
| Algorithms | 2 | 2021 | 1593 | 0.350 |
Why?
| Diabetic Nephropathies | 3 | 2020 | 292 | 0.350 |
Why?
| Magnetic Resonance Imaging | 5 | 2021 | 3264 | 0.340 |
Why?
| Cohort Studies | 7 | 2021 | 5294 | 0.340 |
Why?
| Puberty | 2 | 2022 | 149 | 0.330 |
Why?
| Middle Aged | 13 | 2021 | 28563 | 0.320 |
Why?
| Body Composition | 5 | 2019 | 668 | 0.310 |
Why?
| Sleep Apnea, Obstructive | 1 | 2021 | 237 | 0.300 |
Why?
| Exercise Tolerance | 4 | 2017 | 245 | 0.300 |
Why?
| Protein Kinase C | 1 | 2008 | 314 | 0.290 |
Why?
| Diabetic Cardiomyopathies | 2 | 2016 | 40 | 0.280 |
Why?
| Retrospective Studies | 7 | 2021 | 13433 | 0.270 |
Why?
| Autoimmunity | 1 | 2012 | 852 | 0.270 |
Why?
| Carnitine | 3 | 2019 | 64 | 0.260 |
Why?
| Adiponectin | 2 | 2016 | 231 | 0.250 |
Why?
| Aged | 11 | 2020 | 20495 | 0.240 |
Why?
| Lipids | 4 | 2017 | 614 | 0.240 |
Why?
| Muscle Contraction | 3 | 2014 | 415 | 0.240 |
Why?
| Leg | 5 | 2021 | 249 | 0.230 |
Why?
| Age Factors | 3 | 2020 | 3114 | 0.230 |
Why?
| Endocrine System Diseases | 1 | 2023 | 31 | 0.230 |
Why?
| Muscle Strength | 2 | 2017 | 290 | 0.230 |
Why?
| Reproducibility of Results | 7 | 2023 | 2977 | 0.220 |
Why?
| Vascular Stiffness | 2 | 2019 | 429 | 0.220 |
Why?
| Colorado | 5 | 2020 | 4325 | 0.220 |
Why?
| Biomarkers | 6 | 2019 | 3662 | 0.220 |
Why?
| Carbon Isotopes | 4 | 2019 | 116 | 0.220 |
Why?
| Double-Blind Method | 3 | 2019 | 1711 | 0.210 |
Why?
| Sex Factors | 3 | 2017 | 1860 | 0.210 |
Why?
| Actigraphy | 2 | 2019 | 102 | 0.210 |
Why?
| Cardiorespiratory Fitness | 2 | 2019 | 40 | 0.210 |
Why?
| Melatonin | 2 | 2019 | 110 | 0.200 |
Why?
| Bacteroidetes | 1 | 2021 | 22 | 0.200 |
Why?
| Alopecia | 1 | 2021 | 35 | 0.200 |
Why?
| Firmicutes | 1 | 2021 | 20 | 0.200 |
Why?
| Sleep Wake Disorders | 2 | 2019 | 289 | 0.190 |
Why?
| Contraceptive Devices, Female | 1 | 2020 | 9 | 0.190 |
Why?
| Child, Preschool | 8 | 2022 | 9755 | 0.190 |
Why?
| Klinefelter Syndrome | 1 | 2021 | 53 | 0.190 |
Why?
| Protein Biosynthesis | 2 | 2017 | 408 | 0.190 |
Why?
| Body Weight | 2 | 2019 | 958 | 0.190 |
Why?
| Ovarian Reserve | 1 | 2020 | 13 | 0.190 |
Why?
| Sex Chromosome Disorders of Sex Development | 1 | 2020 | 8 | 0.190 |
Why?
| Drug Implants | 1 | 2020 | 71 | 0.190 |
Why?
| Carotid Intima-Media Thickness | 2 | 2018 | 68 | 0.190 |
Why?
| Time Factors | 5 | 2019 | 6682 | 0.190 |
Why?
| Primary Ovarian Insufficiency | 1 | 2020 | 30 | 0.190 |
Why?
| Parental Leave | 1 | 2020 | 13 | 0.180 |
Why?
| Physicians, Women | 1 | 2020 | 53 | 0.180 |
Why?
| Glucose Metabolism Disorders | 1 | 2019 | 12 | 0.180 |
Why?
| Salaries and Fringe Benefits | 1 | 2020 | 55 | 0.180 |
Why?
| Prednisolone | 1 | 2019 | 76 | 0.180 |
Why?
| Arginine | 2 | 2019 | 254 | 0.180 |
Why?
| Aorta | 2 | 2019 | 368 | 0.180 |
Why?
| United States | 3 | 2021 | 13272 | 0.180 |
Why?
| Liraglutide | 1 | 2019 | 24 | 0.180 |
Why?
| Device Removal | 1 | 2020 | 127 | 0.180 |
Why?
| Sitagliptin Phosphate | 1 | 2019 | 27 | 0.170 |
Why?
| Amino Acids, Essential | 2 | 2009 | 11 | 0.170 |
Why?
| Virilism | 1 | 2019 | 5 | 0.170 |
Why?
| Menstruation Disturbances | 1 | 2019 | 12 | 0.170 |
Why?
| Diabetes Mellitus | 2 | 2020 | 985 | 0.170 |
Why?
| Uromodulin | 1 | 2019 | 28 | 0.170 |
Why?
| Waist Circumference | 1 | 2019 | 132 | 0.170 |
Why?
| Sex Hormone-Binding Globulin | 1 | 2019 | 49 | 0.170 |
Why?
| Adrenocorticotropic Hormone | 1 | 2019 | 153 | 0.170 |
Why?
| Contraceptives, Oral | 1 | 2019 | 26 | 0.170 |
Why?
| Calorimetry, Indirect | 1 | 2019 | 75 | 0.170 |
Why?
| Withholding Treatment | 1 | 2019 | 68 | 0.170 |
Why?
| Diastole | 1 | 2019 | 147 | 0.170 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 44 | 0.170 |
Why?
| Peer Group | 1 | 2020 | 208 | 0.170 |
Why?
| Spironolactone | 1 | 2019 | 38 | 0.170 |
Why?
| Deuterium | 3 | 2015 | 77 | 0.170 |
Why?
| Wakefulness | 1 | 2019 | 141 | 0.160 |
Why?
| Minority Groups | 1 | 2020 | 242 | 0.160 |
Why?
| RNA, Ribosomal, 16S | 1 | 2021 | 535 | 0.160 |
Why?
| Feces | 1 | 2021 | 410 | 0.160 |
Why?
| Cell Respiration | 1 | 2018 | 78 | 0.160 |
Why?
| Erythrocytes | 1 | 2023 | 636 | 0.160 |
Why?
| Intra-Abdominal Fat | 1 | 2018 | 98 | 0.160 |
Why?
| Career Choice | 1 | 2020 | 206 | 0.160 |
Why?
| Cardiotonic Agents | 1 | 2018 | 133 | 0.160 |
Why?
| Saliva | 1 | 2019 | 215 | 0.160 |
Why?
| Psychiatric Status Rating Scales | 1 | 2020 | 531 | 0.160 |
Why?
| Spasms, Infantile | 1 | 2019 | 103 | 0.160 |
Why?
| Universities | 1 | 2020 | 356 | 0.160 |
Why?
| Phosphorus Isotopes | 1 | 2017 | 9 | 0.150 |
Why?
| Incidence | 2 | 2021 | 2527 | 0.150 |
Why?
| Kidney | 4 | 2021 | 1355 | 0.150 |
Why?
| Hindlimb | 1 | 2017 | 138 | 0.150 |
Why?
| Occupational Exposure | 1 | 2020 | 298 | 0.150 |
Why?
| Child Behavior | 1 | 2019 | 238 | 0.150 |
Why?
| Blood Vessels | 1 | 2018 | 193 | 0.150 |
Why?
| Social Media | 1 | 2020 | 163 | 0.150 |
Why?
| Affect | 1 | 2019 | 254 | 0.150 |
Why?
| Human Development | 1 | 2016 | 18 | 0.140 |
Why?
| Social Support | 1 | 2020 | 547 | 0.140 |
Why?
| Prevalence | 2 | 2021 | 2442 | 0.140 |
Why?
| Regional Blood Flow | 2 | 2016 | 427 | 0.140 |
Why?
| Placental Insufficiency | 1 | 2017 | 104 | 0.140 |
Why?
| Bone Density | 1 | 2020 | 451 | 0.140 |
Why?
| Hospitals, Pediatric | 2 | 2017 | 507 | 0.140 |
Why?
| Societies, Medical | 1 | 2020 | 741 | 0.140 |
Why?
| Estrogens | 1 | 2019 | 325 | 0.140 |
Why?
| Metabolome | 1 | 2019 | 299 | 0.140 |
Why?
| Milk Proteins | 2 | 2006 | 39 | 0.140 |
Why?
| Leptin | 1 | 2017 | 233 | 0.130 |
Why?
| Drug Therapy, Combination | 1 | 2018 | 988 | 0.130 |
Why?
| Schools | 1 | 2018 | 428 | 0.130 |
Why?
| Glucocorticoids | 1 | 2019 | 554 | 0.130 |
Why?
| Life Style | 2 | 2018 | 436 | 0.130 |
Why?
| Pneumonia, Viral | 1 | 2020 | 361 | 0.130 |
Why?
| Coronavirus Infections | 1 | 2020 | 349 | 0.130 |
Why?
| Pulse Wave Analysis | 3 | 2021 | 216 | 0.130 |
Why?
| Sex Characteristics | 2 | 2017 | 690 | 0.120 |
Why?
| Phosphorus | 1 | 2014 | 85 | 0.120 |
Why?
| Metabolomics | 1 | 2019 | 550 | 0.120 |
Why?
| Exercise Therapy | 1 | 2018 | 375 | 0.120 |
Why?
| Glomerular Filtration Rate | 4 | 2020 | 697 | 0.120 |
Why?
| Biopsy | 2 | 2008 | 1090 | 0.120 |
Why?
| Mothers | 1 | 2020 | 728 | 0.120 |
Why?
| Surveys and Questionnaires | 2 | 2020 | 4882 | 0.120 |
Why?
| Inflammation Mediators | 1 | 2017 | 515 | 0.120 |
Why?
| Echocardiography | 1 | 2016 | 591 | 0.110 |
Why?
| Adenosine Triphosphate | 2 | 2021 | 456 | 0.110 |
Why?
| Ventricular Function, Left | 1 | 2016 | 493 | 0.110 |
Why?
| Blood Pressure | 2 | 2017 | 1713 | 0.110 |
Why?
| Area Under Curve | 3 | 2008 | 303 | 0.110 |
Why?
| Fetal Growth Retardation | 1 | 2017 | 473 | 0.110 |
Why?
| Pregnancy | 3 | 2020 | 5854 | 0.110 |
Why?
| Pyruvic Acid | 2 | 2010 | 48 | 0.100 |
Why?
| Models, Biological | 1 | 2019 | 1756 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1401 | 0.100 |
Why?
| Physicians | 1 | 2020 | 824 | 0.100 |
Why?
| Emotions | 1 | 2017 | 524 | 0.100 |
Why?
| Hypoglycemia | 1 | 2016 | 406 | 0.100 |
Why?
| Parents | 1 | 2020 | 1256 | 0.100 |
Why?
| Models, Theoretical | 1 | 2015 | 574 | 0.100 |
Why?
| Linear Models | 2 | 2014 | 854 | 0.100 |
Why?
| Disease Progression | 2 | 2022 | 2546 | 0.100 |
Why?
| Cystic Fibrosis | 1 | 2020 | 1003 | 0.100 |
Why?
| Infant, Newborn | 2 | 2020 | 5430 | 0.100 |
Why?
| Treatment Outcome | 6 | 2019 | 9692 | 0.100 |
Why?
| Creatinine | 3 | 2020 | 510 | 0.100 |
Why?
| Hypertension | 1 | 2019 | 1245 | 0.090 |
Why?
| Jet Lag Syndrome | 1 | 2019 | 10 | 0.090 |
Why?
| Acyl Coenzyme A | 2 | 2006 | 31 | 0.090 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 39 | 0.080 |
Why?
| Protein Kinase C beta | 1 | 2008 | 26 | 0.080 |
Why?
| Palmitates | 1 | 2008 | 19 | 0.080 |
Why?
| Diabetes, Gestational | 1 | 2012 | 285 | 0.080 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 171 | 0.080 |
Why?
| Quality Improvement | 1 | 2016 | 1004 | 0.080 |
Why?
| Muscle Cells | 1 | 2007 | 41 | 0.080 |
Why?
| Risk Assessment | 1 | 2017 | 3213 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2005 | 493 | 0.070 |
Why?
| Acetates | 1 | 2007 | 100 | 0.070 |
Why?
| Albuminuria | 2 | 2020 | 195 | 0.070 |
Why?
| Hospitalization | 1 | 2016 | 1914 | 0.070 |
Why?
| Trauma Severity Indices | 1 | 2007 | 128 | 0.070 |
Why?
| Islets of Langerhans | 1 | 2012 | 749 | 0.070 |
Why?
| Muscular Atrophy | 1 | 2006 | 85 | 0.070 |
Why?
| Phenylalanine | 4 | 2009 | 69 | 0.070 |
Why?
| Animals | 8 | 2017 | 34133 | 0.070 |
Why?
| Carbon Dioxide | 1 | 2007 | 237 | 0.070 |
Why?
| Critical Care | 1 | 2010 | 563 | 0.070 |
Why?
| Oxidation-Reduction | 1 | 2008 | 931 | 0.070 |
Why?
| Milk | 1 | 2006 | 127 | 0.070 |
Why?
| Caseins | 1 | 2004 | 22 | 0.060 |
Why?
| Self Report | 1 | 2019 | 730 | 0.060 |
Why?
| Cystatin C | 2 | 2014 | 71 | 0.060 |
Why?
| Albumins | 1 | 2005 | 104 | 0.060 |
Why?
| Fibrinogen | 1 | 2005 | 162 | 0.060 |
Why?
| Physical Exertion | 1 | 2005 | 231 | 0.060 |
Why?
| Placebos | 2 | 2019 | 204 | 0.060 |
Why?
| Stress, Physiological | 1 | 2006 | 433 | 0.060 |
Why?
| Exercise Test | 3 | 2016 | 588 | 0.060 |
Why?
| Dietary Carbohydrates | 1 | 2003 | 154 | 0.060 |
Why?
| Culture Media, Conditioned | 1 | 2022 | 114 | 0.050 |
Why?
| Phosphocreatine | 1 | 2021 | 38 | 0.050 |
Why?
| Regression Analysis | 1 | 2004 | 1018 | 0.050 |
Why?
| Critical Illness | 1 | 2007 | 728 | 0.050 |
Why?
| Gonadotropins | 1 | 2020 | 38 | 0.050 |
Why?
| Hydroxyestrones | 1 | 2000 | 3 | 0.050 |
Why?
| Isoflavones | 1 | 2000 | 24 | 0.050 |
Why?
| Chromosomes, Human, X | 1 | 2020 | 58 | 0.050 |
Why?
| Sex Chromosome Aberrations | 1 | 2020 | 53 | 0.050 |
Why?
| Anti-Mullerian Hormone | 1 | 2020 | 52 | 0.050 |
Why?
| Trisomy | 1 | 2020 | 67 | 0.050 |
Why?
| Causality | 1 | 2019 | 115 | 0.040 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 43 | 0.040 |
Why?
| Administration, Oral | 3 | 2006 | 786 | 0.040 |
Why?
| Hormones | 1 | 2019 | 136 | 0.040 |
Why?
| Rats, Zucker | 2 | 2010 | 34 | 0.040 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1519 | 0.040 |
Why?
| Respiratory Function Tests | 1 | 2020 | 563 | 0.040 |
Why?
| Biological Transport | 2 | 2010 | 392 | 0.040 |
Why?
| Magnetic Resonance Angiography | 1 | 2018 | 214 | 0.040 |
Why?
| Diabetic Angiopathies | 1 | 2019 | 270 | 0.040 |
Why?
| Longitudinal Studies | 1 | 2023 | 2599 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2021 | 1855 | 0.030 |
Why?
| Whey Proteins | 2 | 2006 | 5 | 0.030 |
Why?
| Tertiary Care Centers | 1 | 2016 | 125 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2016 | 105 | 0.030 |
Why?
| Physicians, Primary Care | 1 | 2018 | 243 | 0.030 |
Why?
| Sheep | 1 | 2017 | 769 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1600 | 0.030 |
Why?
| Infant | 2 | 2019 | 8523 | 0.030 |
Why?
| Oxidative Stress | 1 | 2021 | 1204 | 0.030 |
Why?
| Rabbits | 2 | 2005 | 808 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2018 | 1423 | 0.030 |
Why?
| Stress, Mechanical | 1 | 2016 | 440 | 0.030 |
Why?
| Weight Loss | 1 | 2018 | 663 | 0.030 |
Why?
| Energy Metabolism | 2 | 2010 | 783 | 0.030 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 145 | 0.030 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2014 | 198 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 2016 | 705 | 0.030 |
Why?
| Cholesterol, LDL | 1 | 2014 | 326 | 0.030 |
Why?
| Diet | 1 | 2000 | 1168 | 0.030 |
Why?
| Glucagon | 1 | 2012 | 97 | 0.030 |
Why?
| Malonyl Coenzyme A | 1 | 2010 | 6 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2014 | 1531 | 0.020 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2010 | 37 | 0.020 |
Why?
| Glycogen | 1 | 2010 | 58 | 0.020 |
Why?
| Sciatic Nerve | 1 | 2010 | 59 | 0.020 |
Why?
| Adaptation, Physiological | 1 | 2014 | 510 | 0.020 |
Why?
| Rats | 2 | 2010 | 5426 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2010 | 396 | 0.020 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 4 | 0.020 |
Why?
| Clinical Protocols | 1 | 2010 | 248 | 0.020 |
Why?
| Lactic Acid | 1 | 2010 | 283 | 0.020 |
Why?
| Primary Health Care | 1 | 2018 | 1625 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 839 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2010 | 757 | 0.020 |
Why?
| Radioactive Tracers | 1 | 2007 | 5 | 0.020 |
Why?
| Citric Acid Cycle | 1 | 2007 | 45 | 0.020 |
Why?
| Breath Tests | 1 | 2007 | 87 | 0.020 |
Why?
| Sodium Bicarbonate | 1 | 2007 | 51 | 0.020 |
Why?
| Cholesterol | 1 | 2008 | 380 | 0.020 |
Why?
| Multienzyme Complexes | 1 | 2006 | 65 | 0.020 |
Why?
| Diglycerides | 1 | 2006 | 60 | 0.020 |
Why?
| Palmitoylcarnitine | 1 | 2005 | 1 | 0.020 |
Why?
| Carbohydrate Sequence | 1 | 2005 | 23 | 0.020 |
Why?
| Methods | 1 | 2005 | 67 | 0.020 |
Why?
| Palmitic Acid | 1 | 2005 | 39 | 0.020 |
Why?
| AMP-Activated Protein Kinases | 1 | 2006 | 179 | 0.020 |
Why?
| Reference Standards | 1 | 2005 | 177 | 0.020 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2006 | 306 | 0.020 |
Why?
| Metabolic Clearance Rate | 1 | 2005 | 111 | 0.020 |
Why?
| Weight Lifting | 1 | 2004 | 30 | 0.020 |
Why?
| Dietary Supplements | 1 | 2008 | 473 | 0.020 |
Why?
| Leucine | 1 | 2004 | 117 | 0.020 |
Why?
| Hydrocortisone | 1 | 2006 | 315 | 0.020 |
Why?
| Patient Discharge | 1 | 2010 | 842 | 0.020 |
Why?
| Phenotype | 1 | 2012 | 3070 | 0.020 |
Why?
| Fluorocarbons | 1 | 2005 | 106 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2005 | 356 | 0.010 |
Why?
| Heart Rate | 1 | 2007 | 756 | 0.010 |
Why?
| Analysis of Variance | 1 | 2006 | 1329 | 0.010 |
Why?
| Blood Proteins | 1 | 2005 | 249 | 0.010 |
Why?
| Phosphorylation | 1 | 2006 | 1733 | 0.010 |
Why?
| Motor Activity | 1 | 2006 | 679 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2005 | 2123 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2005 | 2933 | 0.010 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2000 | 38 | 0.010 |
Why?
| Premenopause | 1 | 2000 | 109 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2005 | 2491 | 0.010 |
Why?
| Signal Transduction | 1 | 2006 | 4902 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2000 | 1994 | 0.000 |
Why?
|
|
Cree-Green's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|